Cargando…
Reduction of aluminum ion neurotoxicity through a small peptide application – NAP treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common cause of dementia in late life. It is difficult to precisely diagnose AD at early stages, making biomarker search essential for further developments. The objective of this study was to identify protein biomarkers associated with aluminum ions toxicity (AD-...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taiwan Food and Drug Administration
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296191/ https://www.ncbi.nlm.nih.gov/pubmed/30987727 http://dx.doi.org/10.1016/j.jfda.2018.11.009 |